Literature DB >> 18817145

Long term effects of one or two doses of hepatitis B vaccine in adults after five years.

Gholam Ali Ghorbani1, Seyed Moaied Alavian, Hamid Reza Ghadimi.   

Abstract

The aim of this study is to evaluate hepatitis B vaccine protection in those adults who have taken one or two does of vaccine before. It was a retrospective cross sectional study was conducted on fifty-six military personnel in Tehran, Iran in the spring 2007. Demographic data such as age, marital status, education level, number of vaccine doses injected and, type of vaccine and date of last vaccination was collected. Their serum was tested for HBs Ab, HBc Ab and HBs Ag and finally the results were analyzed by SPSS software. All individuals were male with the mean age of 33.9+/-8.9 years. Twelve individuals who had only received one dose of injected vaccine had no antibody against HBsAg and no protection against hepatitis B virus. Of forty-four individuals that had received two doses of injected vaccine, 27 persons (61.4%) were protected and had serum HBsAb more than 10 MIU mL(-1). In conclusion one dose of HBV vaccine cannot produce immunity for five years but two doses of HBV vaccine can produce immunity for five years. However, HBsAb should be tested to make sure of immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817145     DOI: 10.3923/pjbs.2008.660.663

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  4 in total

1.  Knowledge, attitudes and practice of Iranian medical specialists regarding hepatitis B and C.

Authors:  Ali Kabir; Seyed Vahid Tabatabaei; Siamak Khaleghi; Shahram Agah; Amir Hossein Faghihi Kashani; Mehrdad Moghimi; Fahimeh Habibi Kerahroodi; Seyed-E-Hoda Alavian; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

2.  High hepatitis B virus load in a patient with severe polyarthritis nodosa.

Authors:  Gholam Ali Ghorbani; Gholam Hossein Alishiri; Haddi Khajeh Pour
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

3.  Knowledge, attitude, and performance of medical staff of teaching healthcare settings about hepatitis B and C in Isfahan, Iran.

Authors:  Behrooz Ataei; Mohsen Meidani; Maryam Khosravi; Farzin Khorvash; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2014-12-31

4.  Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010-2020.

Authors:  Sijia Shen; Shen Ge; Zheng Zhang; Jianxin Ma; Yang Jiao; Qian Li; Yan Liang; Shuming Li
Journal:  Vaccines (Basel)       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.